Nationwide surveillance of bacterial respiratory pathogens conducted by the surveillance committee of Japanese Society of Chemotherapy, the Japanese Association for Infectious Diseases, and the Japanese Society for Clinical Microbiology in 2010: General view of the pathogens' antibacterial susceptibility

Journal of Infection and Chemotherapy

Volumn 21, Issue 6, 2015, Pages 410-420

  Yanagihara, Katsunori ^a,ag   Kadota, Junichi ^a,ad   Aoki, Nobuki ^a,q   Matsumoto, Tetsuya ^a   Yoshida, Masaki ^a   Yagisawa, Morimasa ^a   Oguri, Toyoko ^a   Sato, Junko ^a   Ogasawara, Kazuhiko ^a   Wakamura, Tomotaro ^a   Sunakawa, Keisuke ^a   Watanabe, Akira ^a   Iwata, Satoshi ^a   Kaku, Mitsuo ^a   Hanaki, Hideaki ^b   Ohsaki, Yoshinobu ^c   Watari, Tomohisa ^c   Toyoshima, Eri ^c   Takeuchi, Kenichi ^d   Shiokoshi, Mayumi ^d   Takeda, Hiroaki ^e   Miki, Makoto ^f   Kumagai, Toshio ^f   Nakanowatari, Susumu ^f   Takahashi, Hiroshi ^g   Utagawa, Mutsuko ^g   Nishiya, Hajime ^h   Kawakami, Sayoko ^h   Kobayashi, Nobuyuki ⁱ   Takasaki, Jin ⁱ   Mezaki, Kazuhisa ⁱ   Konosaki, Hisami ⁱ   Aoki, Yasuko ^j   Yamamoto, Yumiko ^j   Shoji, Michi ^j   Goto, Hajime ^k   Saraya, Takeshi ^k   Kurai, Daisuke ^k   Okazaki, Mitsuhiro ^k   Niki, Yoshihito ^l   Yoshida, Koichiro ^l   Kawana, Akihiko ^m   Saionji, Katsu ^m   Fujikura, Yuji ^m   Miyazawa, Naoki ⁿ   Kudo, Makoto ⁿ   Sato, Yoshimi ⁿ   Yamamoto, Masaki ⁿ   Yoshida, Takashi ^o   Nakamura, Masahiko ^o   Tsukada, Hiroki ^p   Imai, Yumiko ^p   Tsukada, Ayami ^p   Kawasaki, Satoshi ^q   Honma, Yasuo ^q   Yamamoto, Toshinobu ^r   Ban, Nobuyoshi ^r   Mikamo, Hiroshige ^s   Sawamura, Haruki ^s   Miyara, Takayuki ^t   Toda, Hirofumi ^t   Sato, Kaori ^t   Nakamura, Tadahiro ^u   Fujikawa, Yasunori ^u   Mitsuno, Noriko ^u   Mikasa, Keiichi ^v   Kasahara, Kei ^v   Sano, Reiko ^v   Sugimoto, Keisuke ^w   Asari, Seishi ^x   Nishi, Isao ^x   Toyokawa, Masahiro ^x   Miyashita, Naoyuki ^y   Koguchi, Yutaka ^y   Kusano, Nobuchika ^z   Mihara, Eiichirou ^z   Kuwabara, Masao ^aa   Watanabe, Yaeko ^aa   Kawasaki, Yuji ^ab   Takeda, Kenichi ^ab   Tokuyasu, Hirokazu ^ab   Masui, Kayoko ^ab   Negayama, Kiyoshi ^ac   Hiramatsu, Kazufumi ^ad   Aoki, Yosuke ^ae   Fukuoka, Mami ^ae   Magarifuchi, Hiroki ^ae   Nagasawa, Zenzo ^ae   Suga, Moritaka ^af   Muranaka, Hiroyuki ^af   Morinaga, Yoshitomo ^ag   Honda, Junichi ^ah   Fujita, Masaki ^ai   more..

^a Japanese Association for Infectious Diseases (JAID)   (Japan)

^b KITASATO INSTITUTE   (Japan)

^c ASAHIKAWA MEDICAL COLLEGE   (Japan)

^d Iwate Prefectural Central Hospital   (Japan)

^e Saiseikai Yamagata Saisei Hospital   (Japan)

^f Sendai Red Cross Hospital   (Japan)

^g Saka General Hospital   (Japan)

^h TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

ⁱ NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^j NATIONAL HOSPITAL ORGANIZATION TOKYO MEDICAL CENTER   (Japan)

^k KYORIN UNIVERSITY   (Japan)

^l SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^m NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

ⁿ YOKOHAMA CITY UNIVERSITY HOSPITAL   (Japan)

^o TOYAMA PREFECTURAL CENTRAL HOSPITAL   (Japan)

^p NIIGATA CITY GENERAL HOSPITAL   (Japan)

^q Shinrakuen Hospital   (Japan)

^r Kasugai Municipal Hospital   (Japan)

^s AICHI MEDICAL UNIVERSITY HOSPITAL   (Japan)

^t KINKI UNIVERSITY   (Japan)

^u OSAKA CITY GENERAL HOSPITAL   (Japan)

^v NARA MEDICAL UNIVERSITY   (Japan)

^w Red Cross Kobe Hospital   (Japan)

^x OSAKA UNIVERSITY HOSPITAL   (Japan)

^y KAWASAKI MEDICAL SCHOOL   (Japan)

^z OKAYAMA UNIVERSITY HOSPITAL   (Japan)

^aa HIROSHIMA PREFECTURAL HOSPITAL   (Japan)

^ab MATSUE RED CROSS HOSPITAL   (Japan)

^ac KAGAWA UNIVERSITY HOSPITAL   (Japan)

^ad OITA UNIVERSITY   (Japan)

^ae SAGA UNIVERSITY   (Japan)

^af SAISEIKAI KUMAMOTO HOSPITAL   (Japan)

^ag NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^ah ST MARY S HOSPITAL   (Japan)

^ai FUKUOKA UNIVERSITY   (Japan)

more..

Author keywords

Resistance; Respiratory tract infection; Surveillance; Susceptibility

Indexed keywords

ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; BACTERIAL INFECTIONS; BACTERIUM; COMMUNICABLE DISEASES; DRUG EFFECTS; HUMAN; JAPAN; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; RESPIRATORY TRACT INFECTIONS;

ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL INFECTIONS; COMMUNICABLE DISEASES; DRUG RESISTANCE, BACTERIAL; HUMANS; JAPAN; MICROBIAL SENSITIVITY TESTS; RESPIRATORY TRACT INFECTIONS;

EID: 84939989425     PISSN: 1341321X     EISSN: 14377780     Source Type: Journal    
DOI: 10.1016/j.jiac.2015.02.008     Document Type: Article

References (12)

1. Niki Y., Hanaki H., Yagisawa M., Kohno S., Aoki N., Watanabe A., et al. The first nationwide surveillance of bacterial respiratory pathogens conducted by the Japanese Society of Chemotherapy. Part 1: A general view of antibacterial susceptibility. JInfect Chemother 2008, 14:279-290.
2. Watanabe A., Yanagihara K., Matsumoto T., Kohno S., Aoki N., Oguri T., et al. Nationwide surveillance of bacterial respiratory pathogens conducted by the surveillance committee of Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Clinical Microbiology in 2009: general view of the pathogens' antibacterial susceptibility. JInfect Chemother 2012, 18:609-620.
3. CLSI Performance standards for antimicrobial susceptibility testing. M100-S20 2010, Clinical and Laboratory Standards Institute.
4. CLSI Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard 2008, Clinical and Laboratory Standards Institute, M7-A8. 8th ed.
5. Livermore D.M., Warner M., Mushtaq S. Evaluation of the chromogenic Cica-beta-test for detecting extended-spectrum, Ampc and metallo-beta-lactamases. JAntimicrob Chemother 2007, 60:1375-1379.
6. Lodise T.P., Graves J., Evans A., Graffunder E., Helmecke M., Lomaestro B.M., et al. Relationship between vancomycin mic and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin. Antimicrob Agents Chemother 2008, 52:3315-3320.
7. Hoshino T., Sato Y., Toyonaga Y., Hanaki H., Sunakawa K. Drug-Resistant Pathogen Surveillance Group in Pediatric Infectious D. Nationwide survey of the development of drug resistance in the pediatric field in 2007 and 2010: drug sensitivity of Haemophilus influenzae in Japan (second report). JInfect Chemother 2013, 19:495-503.
8. Yagi T., Kurokawa H., Shibata N., Shibayama K., Arakawa Y. Apreliminary survey of extended-spectrum beta-lactamases (ESBLs) in clinical isolates of Klebsiella pneumoniae and Escherichia coli in Japan. FEMS Microbiol Lett 2000, 184:53-56.
9. Chong Y., Yakushiji H., Ito Y., Kamimura T. Clinical and molecular epidemiology of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a long-term study from Japan. Eur J Clin Microbiol Infect Dis 2011, 30:83-87.
10. Yamaguchi K., Ishii Y., Tateda K., Iwata M., Watanabe N., Shinagawa M., et al. Nationwide surveillance of parenteral antibiotics containing meropenem activities against clinically isolated strains in 2012. Jpn J Antibiot 2014, 67:73-107.
11. CLSI Performance standards for antimicrobial susceptibility testing. M100-S21 2011, Clinical and Laboratory Standards Institute.
12. CLSI Performance standards for antimicrobial susceptibility testing. M100-S22 2012, Clinical and Laboratory Standards Institute.